General Information of the Compound
| Compound ID |
CP0421287
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]-5-fluoro-2-(trifluoromethyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H22ClF4N5O
|
||||||||||||||||||
| Molecular Weight |
531.941
|
||||||||||||||||||
| Canonical SMILES |
CN1CCN(CC1)C1=Nc2ccccc2N(NC(=O)c2cc(F)ccc2C(F)(F)F)c2ccc(Cl)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H22ClF4N5O/c1-34-10-12-35(13-11-34)24-19-14-16(27)6-9-22(19)36(23-5-3-2-4-21(23)32-24)33-25(37)18-15-17(28)7-8-20(18)26(29,30)31/h2-9,14-15H,10-13H2,1H3,(H,33,37)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KRULJODHDPRKER-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor